Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Novel ADC Targets, Breast Cancer

Pamela Munster

MD

🏢University of California San Francisco🌐USA

Professor of Medicine and Co-Director, Early Phase Clinical Trials Unit

44
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Dr. Pamela Munster is a clinical investigator specializing in early-phase trials of novel cancer therapeutics at UCSF. She has led studies of ADCs targeting B7-H4 and ROR1 in breast cancer and other solid tumors. Her program evaluates emerging ADC targets beyond established ones like HER2 and TROP2, contributing to the pipeline of next-generation ADC therapeutics through Phase I/II trials.

Share:

🧪Research Fields 研究领域

B7-H4 ADC breast cancer
ROR1 zilovertamab vedotin
novel ADC targets
early phase oncology trials
breast cancer novel therapeutics

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Pamela Munster 的研究动态

Follow Pamela Munster's research updates

留下邮箱,当我们发布与 Pamela Munster(University of California San Francisco)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment